Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AptarGroup, Inc. Common Stock (NY:ATR)

145.00 +2.69 (+1.89%)
Delayed Quote Updated: 10:54 AM EST, Nov 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about AptarGroup, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Aptar Reports Third Quarter 2026 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Increases Quarterly Dividend to $0.50 Per Share
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Taps Pharma Packaging Veteran Virginie Maes as President of its Pharma Business
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports Second Quarter 2026 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Named Among Top 100 of America’s Best Companies by TIME
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Releases 2025 Corporate Sustainability Report
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar to Participate in Upcoming Investor Conferences
From AptarGroup
Via Business Wire
News headline image
Aptar Reports First Quarter 2026 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Recognized as One of America’s Climate Leaders by USA Today for the Fourth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
From Aptar Digital Health
Via Business Wire
News headline image
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar to Participate in Upcoming Investor Conferences
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports Fourth Quarter and Annual 2025 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Announces 2026 Quarterly Conference Call Dates
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
From Aptar Group, Inc.
Via Business Wire
News headline image
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports Third Quarter 2025 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers
From Aptar Digital Health
Via Business Wire
News headline image
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
From AptarGroup, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.